Today, we are excited to announce the winners of our inaugural BioBuzz Awards. The BioBuzz Awards are a celebration of the exciting and groundbreaking work being done by the BioHealth Capital Region (BHCR) life science community and the individuals that make innovation happen across Maryland, Virginia, and Washington, D.C. The award categories include: The Community Impact Leader […]
GlycoMimetics CMO Helen Thackray, MD, participated in a Pharmacy Times interview on rivipansel data presented at the 62nd ASH Annual Meeting and Exposition. Click here to read more via the Pharmacy Times.
SAN FRANCISCO, Nov. 30, 2020 /PRNewswire/ — MapLight Therapeutics today announced a $8.1 million grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF), to undertake a large-scale, systematic investigation of the brain circuits and mechanisms that are responsible for triggering psychiatric symptoms in Parkinson’s disease. Results will inform identification of novel drug targets and therapeutic strategies to […]
In this conversation, Ms. King and Dr. McMurry-Heath share stories underlying their careers in scientific innovation, from the lab bench to government, consulting, and venture capital; and their experiences as one of the few women CEOs in biotechnology.
Rapid Reshore & Development (RR&D), an alliance of three specialized firms coming together to provide turnkey professional services for the life sciences and biopharmaceutical industries, has announced its official launch to address many of the logistical challenges facing companies developing drugs, vaccines and medical devices. RR&D – comprised of Facility Logix, EwingCole and Biggins Lacy Shapiro & Co – will […]
SAN MATEO, Calif., Oct. 6, 2020 /PRNewswire/ — Sagimet Biosciences, a clinical-stage biotechnology company, announced today that new results from its Phase 2 FASCINATE-1 trial of TVB-2640 in nonalcoholic steatohepatitis (NASH) will be shared in an oral presentation at The Liver Meeting Digital Experience™ 2020 of the American Association for the Study of Liver Diseases (AASLD) to be […]
ROCKVILLE, Md.–(BUSINESS WIRE)–Oct. 5, 2020– GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation for rivipansel for the treatment of sickle cell disease in patients 18 years old and younger. This designation recognizes the significant needs in pediatric patients. “The FDA’s designation recognizes the morbidity […]
Murphy brings a wealth of life sciences capital markets experience and deep knowledge in the enabling technologies and cell therapy sectorsHoltz to remain on the Board of Directors of the Company and retain key elements of his executive role, including overseeing accounting, budgeting, and supporting key business operations Gaithersburg, Maryland – September 9, 2020: — MaxCyte, […]
Descartes-30 engineered to express a unique combination of DNases to eliminate neutrophil extracellular traps (NETs), a key driver of inflammation and clotting in ARDS. Gaithersburg, MD, September 1, 2020 – Cartesian Therapeutics, a fully integrated, clinical-stage biopharmaceutical company developing cell and gene therapies for cancer, autoimmune diseases and respiratory diseases, today announced that it has initiated […]
Four biopharma CEOs discuss with Rob Wright, chief editor of Life Science Leader, how they are leading their organizations and conducting drug development during the COVID-19 pandemic. Appearing in this video are: Jeremy Levin, DPhil, MB, BChir, CEO of Ovid TherapeuticsGil Van Bokkelen, Ph.D., chairman and CEO of AthersysRachel King, CEO, GlycoMimeticsTed Love, M.D., President […]